Diajenta 5 mg Tablet

DPP-4 inhibitor for type 2 diabetes in adults, with diet and exercise — alone or with metformin, sulphonylureas, SGLT2 inhibitors or insulin. No dose change needed in kidney disease.

Adults: 5 mg once daily, at any time, with or without food.

• No dose adjustment for kidney or liver impairment.
• When added to a sulphonylurea or insulin, their dose may need lowering.
• Not for children or type 1 diabetes.

• Allergy to linagliptin
• Type 1 diabetes, diabetic ketoacidosis

Common: nasopharyngitis, cough, low blood sugar (with sulphonylureas/insulin), raised lipase.

Less common: constipation, rash, itching.

Rare but serious: pancreatitis (severe persistent abdominal pain), bullous pemphigoid (blisters), angioedema, severe joint pain, severe allergic reactions.

• Stop and seek help with severe persistent abdominal pain or blistering.
• History of pancreatitis: caution.

Not recommended in pregnancy (insulin preferred) or while breastfeeding.

• Rifampicin (reduces effect)
• Sulphonylureas, insulin (hypoglycaemia)
• ACE inhibitors (possible angioedema)

Generally well tolerated; supportive care.

Store below 30°C.